Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
about
Particularities of allergy in the TropicsCritical care management of systemic mastocytosis: when every wasp is a killer beeFunctional deregulation of KIT: link to mast cell proliferative diseases and other neoplasmsHuman heart as a shock organ in anaphylaxisAnaphylactic reaction to platelet transfusion as the initial symptom of an undiagnosed systemic mastocytosis: a case report and review of the literatureAnaphylaxis: opportunities of stratified medicine for diagnosis and risk assessmentMast Cell Clonal Disorders: Classification, Diagnosis and ManagementAdvances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromesTarget interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growthWhen yellow jackets attack: recurrent and severe anaphylactic reactions to insect bites and stings.High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.Mastocytosis.The presence of mast cell clonality in patients with unexplained anaphylaxis.Hymenoptera Allergy and Mast Cell Activation Syndromes.Eosinophilic myeloproliferative disordersMastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype.Mast cell activation syndrome: Proposed diagnostic criteria.World allergy organization guidelines for the assessment and management of anaphylaxis.Telangiectasia macularis eruptiva perstans: more than skin deep.Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology.PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeabilityIdentification of risk factors of severe hypersensitivity reactions in general anaesthesiaGuideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental MediciIncreased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosisIntestinal mast cell levels control severity of oral antigen-induced anaphylaxis in miceConcomitant chronic pulmonary diseases and their association with hospital outcomes in patients with anaphylaxis and other allergic conditions: a cohort study.Antibiotics Are the Most Commonly Identified Cause of Perioperative Hypersensitivity ReactionsThe tyrosine kinase network regulating mast cell activation.Mastocytosis: a disease of the hematopoietic stem cellThe problem of anaphylaxis and mastocytosis.The Role of TRAF4 and B3GAT1 Gene Expression in the Food Hypersensitivity and Insect Venom Allergy in Mastocytosis.Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy.Food-induced anaphylaxis: mast cells as modulators of anaphylactic severity.Non-steroidal anti-inflammatory drug hypersensitivity: association with elevated basal serum tryptase?Neonatal onset diffuse cutaneous mastocytosis: a case report and review of the literature.Mastocytosis: oral implications of a rare disease.Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options.Update on diagnosis and treatment of mastocytosis.Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.Insect allergy.
P2860
Q26314626-8B0F2BF8-D97B-421C-8EC1-1AA16C286D6AQ26865872-B398FFAE-A559-48D2-8589-D2FE985A6E45Q26995624-365F77B0-75E3-4386-BEC6-AC72A1B74E40Q27002411-1E7CA1CF-352E-4F38-84C1-1E6EB4F6014EQ27011610-F3385992-745F-4BE3-BEBD-8EBB21EEBC25Q27023498-37D05E22-37BD-461C-BF52-51588B233D09Q28070386-B0B15B91-88C7-4232-8E5B-D4B3DFF027C1Q28078468-B5EBC46E-5738-4E64-92A3-0F1E8931D1E0Q28828739-5D2D2CBE-6126-42AF-8450-F171D800D315Q33157978-080C3193-5499-406E-BEDE-CE18175B1DFFQ33163450-D022CA9E-3AE5-41BD-9D64-A5E7275FE6DAQ33163541-55106284-F4ED-48F4-A409-91846C4D96DAQ33164531-2CC11E60-72E4-4AB9-9B3A-125F9B5652A4Q33166619-0DC1DE30-8D94-4A20-98FD-1CF990BB0341Q33881283-0DAB685D-FE17-421D-8566-7769AF8F732DQ34017091-97BBEDFF-F494-4E05-A6F4-078A19B012ABQ34024510-00C3DB8D-FA5D-46A0-BCDE-27959F6DF5E5Q34319703-1E43ACB2-C159-4682-9AB0-64BCEE08F8FEQ34413811-8CA4CCD7-D839-4AB9-B477-72E20EE74918Q34423618-9CC8FB41-25C2-4564-8912-270630226C8DQ35553313-25A6AD6A-1DF5-4DB4-B067-434728C29416Q35764873-FE72BA78-2791-4520-B5CB-12AE76133B98Q35777144-C665FB36-E578-4DA6-B2B4-6C95127F4E22Q35951578-6790800E-BE07-470D-B3E7-B3A580B9A6D4Q35967018-D588B7C9-B03B-4E0F-9A3A-95DA95BEEB89Q37065190-7DB6E71B-98D1-4D2F-8DB2-D3629E41FF2DQ37080579-9FB25EAC-B66B-4171-AAE2-AA689B14BD5AQ37158872-06B365F2-9893-46F4-8A47-512741DF40A2Q37228907-DEEA3ED6-913F-4E56-8AC3-D27133E9F4FDQ37343589-418F90E0-5D78-4806-AF14-54F9F78228B1Q37377784-36792AB1-F75C-47FD-BAA1-FB5C4E9C6F73Q37559690-6EA97464-D28C-4993-8F0F-C767752A778AQ37585269-68DB7DCA-F39E-4BD6-B40F-09CE264344D8Q37729070-FB115A25-A789-42B5-8C18-802D972D790DQ37777178-2AC4280B-7E3C-4DC7-89FC-B9E9008CA0BCQ37825551-D17FDAB7-E471-469F-883A-80E327D05112Q37854888-ABA466CB-3DC2-4D0A-AF7B-2667D010361BQ37869373-E0E3EB0E-5ECE-46AC-81B6-6C4A0DD16E63Q37873485-95BBE857-DBDC-4748-B8A1-0FDACB5E7BBDQ37931150-65194D11-0E76-41D7-A2E5-117461A17965
P2860
Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Anaphylaxis in patients with m ...... risk factors in 120 patients.
@en
Anaphylaxis in patients with m ...... risk factors in 120 patients.
@nl
type
label
Anaphylaxis in patients with m ...... risk factors in 120 patients.
@en
Anaphylaxis in patients with m ...... risk factors in 120 patients.
@nl
prefLabel
Anaphylaxis in patients with m ...... risk factors in 120 patients.
@en
Anaphylaxis in patients with m ...... risk factors in 120 patients.
@nl
P2093
P1433
P1476
Anaphylaxis in patients with m ...... risk factors in 120 patients.
@en
P2093
P304
P356
10.1111/J.1398-9995.2007.01569.X
P577
2008-02-01T00:00:00Z